advertisement

WGA Rescources

Flühs D 17

Showing records 1 to 17 | Display all abstracts from Flühs D

95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Dalbah S
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Jabbarli L; Guberina M; Guberina M
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Bechrakis NE; Thomasen H
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Biewald E; Biewald E; Flühs D
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Flühs D
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Flühs D
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Flühs D; Rating P
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Guberina N; Le Guin CHD
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Guberina M; Guberina M; Stuschke M; Stuschke M
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Sauerwein W
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Fiorentzis M
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Bornfeld N; Bornfeld N; Stuschke M
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Bornfeld N
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Stuschke M
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Bornfeld N
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787
95444 Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factors
Bechrakis NE
Clinical and Experimental Ophthalmology 2021; 49: 357-367
95343 Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau Disease
Biewald E; Biewald E
Klinische Monatsblätter für Augenheilkunde 2021; 238: 781-787

Issue 22-2

Change Issue


advertisement

Nidek